News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
255,994 Results
Type
Article (8777)
Company Profile (23)
Press Release (247194)
Section
Business (89906)
Career Advice (527)
Deals (16248)
Drug Delivery (13)
Drug Development (22736)
Employer Resources (34)
FDA (4184)
Job Trends (4657)
News (133676)
Policy (8820)
Tag
2024 BioCapital Digital (2)
2024 Bio NC Digital (1)
2024 Biotech Bay Standard (1)
2024 Biotech Beach Standard (1)
2024 Genetown Digital (1)
2024 Pharm Country Digital (1)
2025 Lone Star Bio Digital (1)
Academia (568)
Adcomms (4)
Allergies (10)
Alliances (18042)
ALS (18)
Alzheimer's disease (284)
Antibody-drug conjugate (ADC) (10)
Approvals (4201)
Artificial intelligence (52)
Autoimmune disease (2)
Automation (3)
Bankruptcy (103)
Best Places to Work (3500)
BIOSECURE Act (1)
Biosimilars (12)
Biotechnology (28)
Bladder cancer (7)
Brain cancer (9)
Breast cancer (47)
Cancer (462)
Cardiovascular disease (24)
Career advice (457)
Career pathing (3)
CAR-T (34)
Cell therapy (111)
Cervical cancer (2)
Clinical research (18691)
Collaboration (189)
Compensation (131)
Complete response letters (4)
COVID-19 (440)
CRISPR (9)
C-suite (89)
Cystic fibrosis (22)
Data (525)
Denatured (3)
Depression (6)
Diabetes (47)
Diagnostics (2264)
Digital health (5)
Diversity, equity & inclusion (13)
Drug discovery (25)
Drug pricing (6)
Drug shortages (4)
Duchenne muscular dystrophy (9)
Earnings (41792)
Editorial (1)
Employer branding (6)
Employer resources (35)
Events (40926)
Executive appointments (286)
FDA (4441)
Featured Employer (7)
Fibrodysplasia Ossificans Progressiva (1)
Frontotemporal dementia (2)
Funding (200)
Gene editing (18)
Generative AI (3)
Gene therapy (51)
GLP-1 (141)
Government (615)
Grass and pollen (1)
Guidances (16)
Healthcare (5501)
Huntington's disease (3)
IgA nephropathy (3)
Immunology and inflammation (13)
Indications (5)
Infectious disease (461)
Inflammatory bowel disease (39)
Inflation Reduction Act (2)
Influenza (8)
Intellectual property (19)
Interviews (57)
IPO (8148)
IRA (3)
Job creations (1284)
Job search strategy (423)
Kidney cancer (6)
Labor market (4)
Layoffs (110)
Leadership (4)
Legal (2576)
Liver cancer (18)
Lung cancer (55)
Lymphoma (24)
Management (11)
Manufacturing (65)
MASH (26)
Medical device (4157)
Medtech (4158)
Mergers & acquisitions (8288)
Metabolic disorders (124)
Multiple sclerosis (6)
NASH (7)
Neurodegenerative disease (12)
Neuropsychiatric disorders (2)
Neuroscience (388)
NextGen: Class of 2025 (1957)
Non-profit (880)
Northern California (876)
Now hiring (3)
Obesity (56)
Opinion (41)
Ovarian cancer (22)
Pain (14)
Pancreatic cancer (14)
Parkinson's disease (36)
Partnered (6)
Patents (35)
Patient recruitment (23)
Peanut (4)
People (26767)
Pharmaceutical (6)
Pharmacy benefit managers (1)
Phase I (5709)
Phase II (8078)
Phase III (6328)
Pipeline (414)
Podcasts (3)
Policy (6)
Postmarket research (707)
Preclinical (2499)
Press Release (67)
Prostate cancer (26)
Psychedelics (4)
Radiopharmaceuticals (111)
Rare diseases (83)
Real estate (2220)
Recruiting (10)
Regulatory (6021)
Reports (15)
Research institute (506)
Resumes & cover letters (69)
Rett syndrome (2)
RSV (2)
Schizophrenia (18)
Series A (30)
Series B (21)
Sickle cell disease (14)
Southern California (652)
Special edition (2)
Sponsored (7)
Startups (1237)
Stomach cancer (1)
Supply chain (11)
United States (6831)
Vaccines (51)
Venture capitalists (5)
Webinars (6)
Weight loss (26)
Women's health (1)
Date
Today (69)
Last 7 days (303)
Last 30 days (1047)
Last 365 days (12065)
2025 (1942)
2024 (12587)
2023 (15000)
2022 (21693)
2021 (22465)
2020 (20441)
2019 (15236)
2018 (11640)
2017 (11597)
2016 (10832)
2015 (14074)
2014 (11203)
2013 (8951)
2012 (9734)
2011 (10387)
2010 (9833)
Location
Africa (226)
Alabama (15)
Alaska (3)
Arizona (59)
Arkansas (3)
Asia (13739)
Australia (1976)
California (1824)
Canada (702)
China (81)
Colorado (90)
Connecticut (96)
Delaware (25)
Europe (29822)
Florida (254)
Georgia (31)
Idaho (23)
Illinois (115)
India (4)
Indiana (64)
Japan (64)
Kansas (29)
Kentucky (10)
Louisiana (6)
Maine (40)
Maryland (243)
Massachusetts (1504)
Michigan (87)
Minnesota (134)
Mississippi (1)
Missouri (20)
Montana (16)
Nebraska (14)
Nevada (21)
New Hampshire (15)
New Jersey (570)
New Mexico (7)
New York (481)
North Carolina (330)
North Dakota (2)
Northern California (876)
Ohio (53)
Oklahoma (4)
Oregon (4)
Pennsylvania (318)
Puerto Rico (1)
Rhode Island (10)
South America (350)
South Carolina (5)
Southern California (652)
Tennessee (32)
Texas (215)
Utah (58)
Virginia (36)
Washington D.C. (7)
Washington State (157)
West Virginia (2)
Wisconsin (20)
255,994 Results for "itochu chemical frontier corporation".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Frontier Medicines to Participate in Two Upcoming March Investor Conferences
February 27, 2025
·
1 min read
Press Releases
IPA and RIBOPRO Partner to Advance mRNA-Driven Antibody Discovery, Unlocking New Frontiers in Immunotherapy
February 26, 2025
·
5 min read
Press Releases
Phio Pharmaceuticals Announces Publication in Frontiers in Immunology
Journal is the official publication of the International Union of Immunological Societies
December 12, 2024
·
4 min read
Press Releases
Frontier Medicines to Present at the 43rd Annual J.P. Morgan Healthcare Conference
January 9, 2025
·
1 min read
Business
Frontier Medicines Appoints Gerardo Ubaghs as Chief Financial Officer and Announces $20 Million Series C Extension
Frontier Medicines Corporation announced the appointment of Gerardo Ubaghs as Chief Financial Officer and the additional close of $20 million extension to its Series C, bringing the total amount raised to $100 million, with the financing slated to accelerate multiple pipeline programs.
June 25, 2024
·
3 min read
Press Releases
Quince Therapeutics Announces Frontiers in Neurology Publication of Long-Term Safety of EryDex in Pediatric Patients with Ataxia-Telangiectasia
January 27, 2025
·
8 min read
Biotech Bay
Frontier Medicines to Participate in Upcoming Investor Conferences - February 27, 2024
Frontier Medicines Corporation announced that Chris Varma, Ph.D., Frontier’s co-founder, chairman, and CEO, will participate in the upcoming Evercore ISI Emerging Private Biotech Conference, TD Cowen Annual Health Care Conference, and Leerink Partners Global Biopharma Conference.
February 27, 2024
·
1 min read
Oncoinvent to Present at Cantor Fitzgerald Frontiers in Radiopharma Virtual Summit
Oncoinvent AS today announced that members of management will participate in a virtual fireside chat at the Cantor Fitzgerald Frontiers in Radiopharma Virtual Summit on Monday, May 20, 2024 at 9:00 a.m. ET.
May 15, 2024
·
2 min read
Biotech Bay
Frontier Medicines Announces Oversubscribed $80 Million Series C Financing to Support Progress of Clinical-Stage Pipeline
Frontier Medicines Corporation announced the close of an oversubscribed $80 million Series C financing.
February 22, 2024
·
4 min read
Biotech Bay
Frontier Medicines to Present at the 42nd Annual J.P. Morgan Healthcare Conference
Frontier Medicines Corporation announced that Chris Varma, Ph.D., Frontier’s co-founder, chairman, and CEO, will present a company overview at the 42nd Annual J.P. Morgan Healthcare Conference on Tuesday, January 9, 2024 at 11:30 a.m. PT.
January 3, 2024
·
1 min read
1 of 25,600
Next
